ZTS250117C125000
- 53.70
- 0.000.00%
Zoetis Newsroom
Weekly Buzz: CES Came and Brought the Pain? That's Unexpected
Wall Street Today: Labor Gains Hurt a Hurting Market
How Is The Market Feeling About Zoetis?
First Earnings Show Beats are Back, December Jobs Climbed but Market Falls Friday | Live Stock
Investors in Zoetis (NYSE:ZTS) Have Unfortunately Lost 18% Over the Last Three Years
An Intrinsic Calculation For Zoetis Inc. (NYSE:ZTS) Suggests It's 33% Undervalued
Animal Health Business Research Report 2024-2030 Featuring Major Players - Bayer, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Heska, Merck, Nutreco, Vetiquinol, Virbac, and Zoetis
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
S&P 500 Positive for 'First Five Days,' Huang Sees Decades till Quantum | Wall Street Today
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Tuesday Market Pulls Back After Nvidia All Time High | Wall Street Today
Is Zoetis Inc. (NYSE: ZTS) Overvalued? Or Is It Worth Buying Now?
Stifel Adjusts Zoetis' Price Target to $180 From $210, Keeps Buy Rating
Market Sells CES Tech News, ISM Tuesday as Nvidia Champions Robots Monday | Live Stock
Stifel Maintains Buy on Zoetis, Lowers Price Target to $180
Zoetis Analyst Ratings
Here's How Much You Would Have Made Owning Zoetis Stock In The Last 10 Years
Stifel Maintains Zoetis(ZTS.US) With Buy Rating, Cuts Target Price to $180
Press Release: Zoetis to Host Webcast and Conference Call on Fourth Quarter and Full Year 2024 Financial Results
Express News | Zoetis Inc : Stifel Cuts Target Price to $180 From $210